103 results
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
6 Jun 24
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
2:57pm
$12M year-to-date, including $7.4 million in Q2’24 so far
Secured continued insider investment through independent board members’ participation … since April 1, 2024 with $6.4 million of this amount due to sales under the ATM facility to fund continuing clinical development. Our independent
8-K
MAIA
MAIA Biotechnology Inc
29 May 24
Submission of Matters to a Vote of Security Holders
4:05pm
. Ratification of Auditors
Stockholders ratified the appointment of Grant Thornton LLP to serve as the Company’s independent registered public accounting firm
8-K
EX-4.2
MAIA
MAIA Biotechnology Inc
23 Apr 24
MAIA Biotechnology Announces $1.00 Million Private Placement
4:05pm
as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding … (acting on the advice of an Independent Third Party, should the Committee elect in its sole discretion to utilize an Independent Third Party
8-K
EX-10.1
MAIA
MAIA Biotechnology Inc
23 Apr 24
MAIA Biotechnology Announces $1.00 Million Private Placement
4:05pm
as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably … report of the Company’s independent registered public accounting firm due to a transition period established by rules of the SEC for newly public
8-K
EX-4.1
MAIA
MAIA Biotechnology Inc
23 Apr 24
MAIA Biotechnology Announces $1.00 Million Private Placement
4:05pm
as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding … by an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and reasonably acceptable
S-8
EX-23.1
20jsdmz
19 Apr 24
Registration of securities for employees
4:01pm
S-8
3sx6xd1oi4w
19 Apr 24
Registration of securities for employees
4:01pm
S-8
EX-5.1
hwu 1fnhpo
19 Apr 24
Registration of securities for employees
4:01pm
8-K
EX-4.1
e6ynzl9x8lcn7
26 Mar 24
MAIA Biotechnology Announces $1.33 Million Private Placement
3:36pm
8-K
EX-10.1
anzozj xn8wh
26 Mar 24
MAIA Biotechnology Announces $1.33 Million Private Placement
3:36pm
8-K
EX-10.1
gxhr 2m2uyc5l41
13 Mar 24
Entry into a Material Definitive Agreement
5:14pm
424B5
4dn3b4n7o8 cs
14 Feb 24
Prospectus supplement for primary offering
5:18pm
8-K
EX-1.1
nblgop9ep ud6znllv
14 Feb 24
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-4.2
z83uaeh 77ege5
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
8-K
EX-4.1
39b3c3i qxol41isz
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
8-K
EX-10.1
b8k4wdr
17 Nov 23
MAIA Biotechnology Announces $4 Million Registered Direct Offering
9:09am
424B5
w9yfk
17 Nov 23
Prospectus supplement for primary offering
9:06am